DE3781863T2 - Bordetella pertussis-polypeptide und toxinantigene. - Google Patents

Bordetella pertussis-polypeptide und toxinantigene.

Info

Publication number
DE3781863T2
DE3781863T2 DE8787850312T DE3781863T DE3781863T2 DE 3781863 T2 DE3781863 T2 DE 3781863T2 DE 8787850312 T DE8787850312 T DE 8787850312T DE 3781863 T DE3781863 T DE 3781863T DE 3781863 T2 DE3781863 T2 DE 3781863T2
Authority
DE
Germany
Prior art keywords
arg
thr
glu
tyr
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787850312T
Other languages
English (en)
Other versions
DE3781863D1 (de
Inventor
Tamas Bartfai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trion Forskning & Utveckling
Original Assignee
Trion Forskning & Utveckling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trion Forskning & Utveckling filed Critical Trion Forskning & Utveckling
Publication of DE3781863D1 publication Critical patent/DE3781863D1/de
Application granted granted Critical
Publication of DE3781863T2 publication Critical patent/DE3781863T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8787850312T 1986-10-20 1987-10-19 Bordetella pertussis-polypeptide und toxinantigene. Expired - Fee Related DE3781863T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8604445A SE455946B (sv) 1986-10-20 1986-10-20 Nya pertussistoxin-polypeptider och antigener samt testsatser, vacciner och intradermala hudtestkompositioner

Publications (2)

Publication Number Publication Date
DE3781863D1 DE3781863D1 (de) 1992-10-29
DE3781863T2 true DE3781863T2 (de) 1993-03-11

Family

ID=20365987

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787850312T Expired - Fee Related DE3781863T2 (de) 1986-10-20 1987-10-19 Bordetella pertussis-polypeptide und toxinantigene.

Country Status (12)

Country Link
US (1) US5225193A (de)
EP (1) EP0266325B1 (de)
JP (1) JP2635641B2 (de)
AT (1) ATE80895T1 (de)
AU (1) AU624066B2 (de)
DE (1) DE3781863T2 (de)
DK (1) DK312088A (de)
FI (1) FI891872A0 (de)
IE (1) IE872802L (de)
PT (1) PT85960B (de)
SE (1) SE455946B (de)
WO (1) WO1988002754A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988004665A1 (en) * 1986-12-22 1988-06-30 Trion Forskning- Och Utvecklings Aktiebolag A new pertussis toxin derived polypeptide and applications thereof
US5000952A (en) * 1988-08-02 1991-03-19 The Board Of Trustees Of The Leland Stanford, Jr. University Polypeptide pertussis toxin vaccine
IT1229766B (it) * 1989-05-19 1991-09-10 Sclavo Spa Peptidi sintetici capaci di stimolare una immunita' t cellulare.
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
DE4430601A1 (de) * 1994-08-22 1996-02-29 Beiersdorf Ag Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander
US10864213B2 (en) 2014-05-12 2020-12-15 Verona Pharma Plc Treatment

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019733B2 (ja) * 1977-06-10 1985-05-17 科研製薬株式会社 蛋白質性活性物質
JPS5767591A (en) * 1980-10-11 1982-04-24 Kaken Pharmaceut Co Ltd Protein element substance and its preparation
JPS5767592A (en) * 1980-10-11 1982-04-24 Kaken Pharmaceut Co Ltd Protein having reassociating properties and its preparation
JPS58222032A (ja) * 1982-06-18 1983-12-23 Teijin Ltd 百日咳毒素のサブユニツト蛋白
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
FR2590483B1 (fr) * 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
CA1340373C (en) * 1986-01-28 1999-02-02 Rino Rappuoli Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin
US4883761A (en) * 1986-03-25 1989-11-28 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin gene: cloning and expression of protective antigen
US4762710A (en) * 1986-06-16 1988-08-09 The United States Of America As Represented By The Department Of Health And Human Services Novel method of preparing toxoid by oxidation and metal ions
WO1988004665A1 (en) * 1986-12-22 1988-06-30 Trion Forskning- Och Utvecklings Aktiebolag A new pertussis toxin derived polypeptide and applications thereof
AU614755B2 (en) * 1987-06-05 1991-09-12 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Autocrine motility factors in cancer diagnosis and management
US5000952A (en) * 1988-08-02 1991-03-19 The Board Of Trustees Of The Leland Stanford, Jr. University Polypeptide pertussis toxin vaccine

Also Published As

Publication number Publication date
SE8604445D0 (sv) 1986-10-20
IE872802L (en) 1988-04-20
PT85960A (en) 1987-11-01
FI891872A (fi) 1989-04-19
AU8152487A (en) 1988-05-06
EP0266325B1 (de) 1992-09-23
US5225193A (en) 1993-07-06
PT85960B (pt) 1990-07-31
DE3781863D1 (de) 1992-10-29
FI891872A0 (fi) 1989-04-19
JPH02500977A (ja) 1990-04-05
SE455946B (sv) 1988-08-22
ATE80895T1 (de) 1992-10-15
JP2635641B2 (ja) 1997-07-30
WO1988002754A1 (en) 1988-04-21
DK312088D0 (da) 1988-06-08
DK312088A (da) 1988-08-10
SE8604445L (sv) 1988-04-21
AU624066B2 (en) 1992-06-04
EP0266325A1 (de) 1988-05-04

Similar Documents

Publication Publication Date Title
NO901899D0 (no) Hiv-peptider, syntetiske hiv-antigener og immunoanalysekit
DE3688246T2 (de) Kunstpolypeptide zum nachweis mykobakterieller infektionen.
ATE126594T1 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
ATE89566T1 (de) Molekuele mit mindestens einer peptidsequenz einer oder mehrerer epitopen eines p.falciparum- produzierten proteins in hepatozyten und zusammensetzungen davon.
Child et al. A review of the applications of immunochemistry to archaeological bone
DE3781863T2 (de) Bordetella pertussis-polypeptide und toxinantigene.
DE69018926D1 (de) Vakzine gegen Bordetella.
DE69034254D1 (de) A-pdgf-rezeptor und dessen verwendung
ATE94880T1 (de) Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung.
DK232988D0 (da) Fremgangsmaade til immunologisk bestemmelse af aminoterminalt prokollagen peptidtype iii og antistoffer til gennemfoerelse heraf.
ES2080955T3 (es) Anticuerpos especificos de la pancreaelastasa 1, procedimiento para su obtencion y equipo de analisis que contiene este tipo de anticuerpos.
Foster et al. Serological and cellular immune responses to non‐structural proteins in animals infected with FMDV
DE69026875T2 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
SE8901566D0 (sv) Nya peptider inkluderande en disulfidbindning
ATE154846T1 (de) Satz zur schnellen aufzählung von granulocyten und verfahren das diesen satz verwendet
NO904129L (no) Antistoffer mot hoeykonserverte aminosyresekvenser fra immunogene forbindelser, fremgangsmaate for fremstilling av antistoffer samt anvendelse derav i immunoanalyser.
GR1000377B (el) Νεα πρωτεινη αναγνωρισεως της κυησεως σε θηλαστικα εφαρμογες στην προωρη ανιχνευση της κυησεως και μεθοδος παρασκευης της εν λογω πρωτεινης.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee